DDX58 and Classic Singleton-Merten Syndrome

Carlos R. Ferreira, Yanick J. Crow, William A. Gahl, Pamela J. Gardner, Raphaela Goldbach‐Mansky, Sun Jin Hur, Adriana A. de Jesus, Michele Nehrebecky, Ji Woo Park, Tracy A. Briggs

Journal of Clinical Immunology · 2018 · 61 citations · 15 references

DOIFull text

Open access

Concepts

Abstract

PURPOSE: Singleton-Merten syndrome manifests as dental dysplasia, glaucoma, psoriasis, aortic calcification, and skeletal abnormalities including tendon rupture and arthropathy. Pathogenic variants in IFIH1 have previously been associated with the classic Singleton-Merten syndrome, while variants in DDX58 has been described in association with a milder phenotype, which is suggested to have a better prognosis. We studied a family with severe, "classic" Singleton-Merten syndrome. METHODS: We undertook clinical phenotyping, next-generation sequencing, and functional studies of type I interferon production in patient whole blood and assessed the type I interferon promoter activity in HEK293 cells transfected with wild-type or mutant DDX58 stimulated with Poly I:C. RESULTS: We demonstrate a DDX58 autosomal dominant gain-of-function mutation, with constitutive upregulation of type I interferon. CONCLUSIONS: DDX58 mutations may be associated with the classic features of Singleton-Merten syndrome including dental dysplasia, tendon rupture, and severe cardiac sequela.

References

15